Out of stock for ordering This brochure informs patients about buprenorphine and medication-assisted treatment for opioid use disorder. It describes addiction and withdrawal, how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process. Publication ID SMA15-4442 Publication Date August 2015 Format Brochure Download Facts About Buprenorphine for Opioid Addiction PDF 749.84 KB Find Related Information Audience Employers Family & Advocates People with Alcohol Use or Abuse Problems as Audience Policymakers Population Group People with Substance Use or Abuse Problems as Population Group You May Also Be Interested In Pharmacologic Guidelines for Treating Individuals with Post-Traumatic Stress Disorder and Co-Occurring Opioid Use Disorders This manual offers guidelines for medication-assisted treatment for people, particularly veterans, living with post-traumatic stress disorder and co-occurring opioid use disorders. It covers screening, concomitant treatment, pharmacotherapy, and multiple misused substances. Follow Directions: How to Use Methadone Safely This fact sheet describes ways to reduce the risks of taking methadone for pain relief or medication-assisted treatment of opioid use disorders. It lists methadone side effects that require emergency attention and offers resources for additional information. TIP 63: Medications for Opioid Use Disorder - Executive Summary The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery. TIP 63: Medications for Opioid Use Disorder - Full Document This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. Federal Guidelines for Opioid Treatment Programs This manual provides guidelines for the operation of opioid treatment programs. It covers patient assessment, treatment planning, and recovery care. The manual also offers guidance for medication-assisted treatment for methadone and buprenorphine, and overdose and relapse prevention. Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder.